International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Autism in Children

Author(s): Cave Stephanie

Issue: Jan/Feb 2001 - Compounding for Pediatric Patients
View All Articles in Issue

Page(s): 18-19

Download in electronic PDF format for $75

Abstract: Autism incorporates most of the characteristics of a metabolic disorder. In this discussion, the author focuses on biochemical markers, causes of autism and treatments.

Related Keywords: autism, autistic, autistic children

Related Categories: MENTAL HEALTH, PEDIATRICS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Autism in Children Cave Stephanie	Jan/Feb 2001 Pg. 18-19
Topical Secretin for the Treatment of Autism King Erin, Toney Steve	Nov/Dec 2001 Pg. 436-437
Unlocking Autism: Is Compounding the Key? Vail Jane	Nov/Dec 2005 Pg. 413-420
PostScription: Compounding Pharmacies and the Successful Treatment of Autism Neurander James A	Nov/Dec 2005 Pg. 487-488
Compounding Naltrexone for the Treatment of Autism Wynn Tom, Brunetti Sarah	Jul/Aug 2009 Pg. 296-299
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Allen Loyd V Jr	Sep/Oct 2006 Pg. 390
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	May/Jun 2007 Pg. 220-225
Current Trends and Emerging Priorities in Compounded Preparations for Children Parrish Richard H II	Sep/Oct 2018 Pg. 358-366
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna	Sep/Oct 2020 Pg. 367-369
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Nahata Milap C	May/Jun 2016 Pg. 247-249
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S	May/Jun 2016 Pg. 257-261
Child-safety Containers/Devices and Compounding Allen Loyd V Jr	Sep/Oct 2017 Pg. 364-370
Sevelamer Suspension in Children with End-Stage Renal Disease McElhiney Linda F	Jan/Feb 2007 Pg. 20-24
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	Jan/Feb 2007 Pg. 5-8
Case Report: Treatment of Labial Adhesions in a Child Fields Shannon W	Jan/Feb 2007 Pg. 27
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise	Jul/Aug 2008 Pg. 365-367
Pediatric Compounding: Coloring Outside the Lines Preckshot John	Jan/Feb 2001 Pg. 6-8
Compounding for Pediatric Patients: Case Reports and Formulations Mixon William, Angelle Patricea, Yoch Douglas	Jan/Feb 2009 Pg. 6-12
Sleepless in America: Compounding with Melatonin Wynn Tom, Rawlings Kate	Jan/Feb 2010 Pg. 10-13
Pediatric Health Care: An Introduction Williams LaVonn A	Jan/Feb 2013 Pg. 6-8
Return to Top